Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 2
2008 2
2009 3
2011 2
2012 3
2013 2
2014 1
2015 3
2016 4
2017 3
2018 3
2019 4
2020 6
2021 6
2022 8
2023 8
2024 8
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.
Chapman OS, Luebeck J, Sridhar S, Wong IT, Dixit D, Wang S, Prasad G, Rajkumar U, Pagadala MS, Larson JD, He BJ, Hung KL, Lange JT, Dehkordi SR, Chandran S, Adam M, Morgan L, Wani S, Tiwari A, Guccione C, Lin Y, Dutta A, Lo YY, Juarez E, Robinson JT, Korshunov A, Michaels JA, Cho YJ, Malicki DM, Coufal NG, Levy ML, Hobbs C, Scheuermann RH, Crawford JR, Pomeroy SL, Rich JN, Zhang X, Chang HY, Dixon JR, Bagchi A, Deshpande AJ, Carter H, Fraenkel E, Mischel PS, Wechsler-Reya RJ, Bafna V, Mesirov JP, Chavez L. Chapman OS, et al. Among authors: deshpande aj. Nat Genet. 2023 Dec;55(12):2189-2199. doi: 10.1038/s41588-023-01551-3. Epub 2023 Nov 9. Nat Genet. 2023. PMID: 37945900 Free PMC article.
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.
Tubío-Santamaría N, Jayavelu AK, Schnoeder TM, Eifert T, Hsu CJ, Perner F, Zhang Q, Wenge DV, Hansen FM, Kirkpatrick JM, Jyotsana N, Lane SW, von Eyss B, Deshpande AJ, Kühn MWM, Schwaller J, Cammann C, Seifert U, Ebstein F, Krüger E, Hochhaus A, Heuser M, Ori A, Mann M, Armstrong SA, Heidel FH. Tubío-Santamaría N, et al. Among authors: deshpande aj. Mol Cancer. 2023 Dec 4;22(1):196. doi: 10.1186/s12943-023-01907-7. Mol Cancer. 2023. PMID: 38049829 Free PMC article.
Transcriptional control of leukemogenesis by the chromatin reader SGF29.
Barbosa K, Deshpande A, Perales M, Xiang P, Murad R, Pramod AB, Minkina A, Robertson N, Schischlik F, Lei X, Sun Y, Brown A, Amend D, Jeremias I, Doench JG, Humphries RK, Ruppin E, Shendure J, Mali P, Adams PD, Deshpande AJ. Barbosa K, et al. Among authors: deshpande aj. Blood. 2024 Feb 22;143(8):697-712. doi: 10.1182/blood.2023021234. Blood. 2024. PMID: 38048593 Free PMC article.
Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
Tiwari A, Tashiro K, Dixit A, Soni A, Vogel K, Hall B, Shafqat I, Slaughter J, Param N, Le A, Saunders E, Paithane U, Garcia G, Campos AR, Zettervall J, Carlson M, Starr TK, Marahrens Y, Deshpande AJ, Commisso C, Provenzano PP, Bagchi A. Tiwari A, et al. Among authors: deshpande aj. Gastroenterology. 2020 Nov;159(5):1882-1897.e5. doi: 10.1053/j.gastro.2020.07.046. Epub 2020 Aug 5. Gastroenterology. 2020. PMID: 32768595 Free PMC article.
Connie J. Eaves (1944-2024).
Kannan N, Deshpande AJ. Kannan N, et al. Among authors: deshpande aj. Nat Rev Cancer. 2024 Jul;24(7):443. doi: 10.1038/s41568-024-00696-5. Nat Rev Cancer. 2024. PMID: 38698125 No abstract available.
Silencing with SAFB: a new role for HOXA9 in AML.
Deshpande AJ, Zhu N. Deshpande AJ, et al. Blood. 2023 Apr 6;141(14):1653-1655. doi: 10.1182/blood.2022019244. Blood. 2023. PMID: 37022737 Free PMC article. No abstract available.
Targeting eIF4G1-dependent translation in melanoma.
Feng Y, Radaeva M, Amiri M, Deshpande AJ, Olson S, Jovanovic P, Pass I, Deng Q, Lazar I, Murad R, Molinolo A, Kim H, Sergienko E, Villaneuva J, Topisirovic I, Jackson M, Sonenberg N, Cherkasov A, Ronai ZA. Feng Y, et al. Among authors: deshpande aj. bioRxiv [Preprint]. 2024 Nov 21:2024.11.20.624566. doi: 10.1101/2024.11.20.624566. bioRxiv. 2024. PMID: 39605602 Free PMC article. Preprint.
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
Abla O, Ries RE, Triche T Jr, Gerbing RB, Hirsch B, Raimondi S, Cooper T, Farrar JE, Buteyn N, Harmon LM, Wen H, Deshpande AJ, Kolb EA, Gamis AS, Aplenc R, Alonzo T, Meshinchi S. Abla O, et al. Among authors: deshpande aj. Blood Adv. 2024 Apr 23;8(8):2005-2017. doi: 10.1182/bloodadvances.2023010805. Blood Adv. 2024. PMID: 38306602 Free PMC article.
The Role of DOT1L in Normal and Malignant Hematopoiesis.
Arnold O, Barbosa K, Deshpande AJ, Zhu N. Arnold O, et al. Among authors: deshpande aj. Front Cell Dev Biol. 2022 May 26;10:917125. doi: 10.3389/fcell.2022.917125. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35712672 Free PMC article. Review.
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2.
Pandey K, Acharya A, Pal D, Jain P, Singh K, Durden DL, Kutateladze TG, Deshpande AJ, Byrareddy SN. Pandey K, et al. Among authors: deshpande aj. Antiviral Res. 2024 Jul;227:105904. doi: 10.1016/j.antiviral.2024.105904. Epub 2024 May 8. Antiviral Res. 2024. PMID: 38729306
63 results